This regulation is affected by APOE polymorphism, and APOE ɛ4 polymorphism is known to increase the risk of atherosclerosis and neurodegenerative disorders, including Alzheimer’s disease and dementia. This evidence concerns the gene APOE and Alzheimer disease.